Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Biomaterials. 2018 Jan 19;161:69–80. doi: 10.1016/j.biomaterials.2018.01.027

Figure 3. Mobilization of endogenous stem cell populations in blood circulation 3 days after intravenous HDL-SP administration in diabetic mice with hindlimb ischemia.

Figure 3

(A) The serum levels of NEP in normal and diabetic mice (n = 3; **p < 0.01). FACS analyses of (B) MSC population (CD29+CD105+CD145−) in total PBMCs from diabetic mice (n = 4; **p < 0.01 versus other control groups) and (C) EPC population (CD31+CD133+CD309+) in total PBMCs from diabetic mice (n = 4; **p < 0.01 versus PBS and LIPO-SP groups, +p < 0.05 versus sham, HDL, and SP groups).